HIV Treatment

MONTREAL, April 29, 2026 Pharmascience Canada has announced the official launch of ᴾʳpms-DOLUTEGRAVIR (dolutegravir tablets), marking an important milestone...

Rahway, New Jersey, USA – April 21, 2026 In a major breakthrough for HIV therapeutics, Merck has received U.S....

Barcelona, Spain – October 15, 2025 – Gilead Sciences, Inc. (NASDAQ: GILD) unveiled new data across its HIV prevention...